Showing results (1271-1280 of 2,301) with videos related to

Sort By:
Pageof 231
Chest|October 19, 2024
Comparative Effectiveness of Albumin vs No Albumin on Renal Replacement Therapy and Mortality in Patients With Septic Shock and Renal ImpairmentAsad E Patanwala, Alexander H Flannery, Hemalkumar B Mehta, et al.
European Journal of Human Genetics : EJHG|August 19, 2010
Alternative splice variants of the USH3A gene Clarin 1 (CLRN1)Hanna Västinsalo, Reetta Jalkanen, Astra Dinculescu, et al.
Spine|April 7, 2007
Key factors in back disability prevention: a consensus panel on their impact and modifiabilityJaime Guzman, Jill Hayden, Andrea D Furlan, et al.
Plos Neglected Tropical Diseases|May 23, 2015
The Heme Transport Capacity of LHR1 Determines the Extent of Virulence in Leishmania amazonensisRebecca L Renberg, Xiaojing Yuan, Tamika K Samuel, et al.
Kidney Medicine|August 17, 2021
Sepsis-Associated Acute Kidney Disease and Long-term Kidney OutcomesAlexander H Flannery, Xilong Li, Natalie L Delozier, et al.
Australasian Journal of Ultrasound in Medicine|August 18, 2022
Diastolic flow in the left ventricular outflow tract - A normal physiological and underappreciated echocardiographic findingBrian Cowie, Ben Costello, Leah Wright, et al.
Journal of Developmental and Behavioral Pediatrics : JDBP|April 14, 2005
Predictors of internalizing symptoms among very low birth weight young womenMaureen Hack, Eric A Youngstrom, Lydia Cartar, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|October 1, 1996
Assessing and overcoming situational obstacles to dietary adherence in adolescents with IDDMD G Schlundt, M Rea, M Hodge, et al.
Bioorganic & Medicinal Chemistry Letters|November 1, 2008
N-((8-hydroxy-5-substituted-quinolin-7-yl)(phenyl)methyl)-2-phenyloxy/amino-acetamide inhibitors of ADAMTS-5 (Aggrecanase-2)Adam M Gilbert, Matthew G Bursavich, Sabrina Lombardi, et al.
Vaccine|March 9, 2020
Clinical trial to assess immunogenicity of high-dose, adjuvanted, and recombinant influenza vaccines against cell-grown A(H3N2) viruses in adults 65 to 74 years, 2017-2018Edward A Belongia, Min Z Levine, Oluwatosin Olaiya, et al.
Pageof 231